The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

figure

posted on 2021-01-07, 12:29 authored by Joseph B. Domachowske, Evan J. Anderson, Mitchell Goldstein

<p><strong>Article full text</strong></p> <p><br> There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2021.<b> </b></p><br><p></p>

History

Related Materials

1.
URL - References https://link.springer.com/article/10.1007/s40121-020-00383-6
2.
DOI - Is supplement to The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

Usage metrics

Infectious Diseases and Therapy

Categories

Keywords

American Academy of Pediatrics High-risk preterm infants Immunoprophylaxis Monoclonal antibody National Perinatal Association Palivizumab Respiratory syncytial virus Treatment Vaccine

Licence

Exports